Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should patients with acute lymphoblastic leukemia receive hematopoietic stem-cell transplant from an unrelated donor?

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Jamieson CH et al. (2003) Allogeneic hematopoietic cell transplantation for patients with high risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience. Exp Hematol 31: 981–986

    Article  Google Scholar 

  2. Lee S et al. (2003) Minimal residual disease-based role of imatinib as a first-line interim therapy prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 102: 3068–3070

    Article  CAS  Google Scholar 

  3. Thomas X et al. (2004) Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 22: 4075–4086

    Article  CAS  Google Scholar 

  4. Coustan-Smith E et al. (2000) Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 96: 2691–2696

    CAS  PubMed  Google Scholar 

  5. Hollerman A et al. (2004) Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 6: 533–542

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forman, S. Should patients with acute lymphoblastic leukemia receive hematopoietic stem-cell transplant from an unrelated donor?. Nat Rev Clin Oncol 2, 18–19 (2005). https://doi.org/10.1038/ncponc0060

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0060

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing